Continuous Hemoglobin Evaluation
This trial is active, not recruiting.
|Sponsor||University of California, Davis|
|Start date||November 2012|
|End date||November 2015|
|Trial size||70 participants|
|Trial identifier||NCT01811342, 348788|
Evaluate potential sources of error that affect the accuracy of continuous hemoglobin monitoring.
Patients requiring intra-operative hemoglobin measurement.
Evaluation of the Masimo Continuous Hemoglobin Monitor with Polar Plot Methodology
time frame: One year
Male or female participants at least 18 years old.
- Patients undergoing elective surgery.
|Official title||Evaluation of the Masimo Continuous Hemoglobin Monitor With Polar Plot Methodology|
Call for more information